Stock Quote

Commonwealth Biotechnologies, Inc (CBTE.DE) (Xetra)
As of  28 Nov 2008
3.00EUR
Price Change
+0.00
Percent Change
+0.00%
 
€3.00
28 Nov 2008
+0.00%
€3.00
--
200
€3.00
€3.00
€3.00
€3.00
1.39
0

Research Another Stock: Symbol Look-up
No news stories for this company within the last 30 days.
Klarman's Baupost Group Bets Big on Capitalsource, News Corp.
Monday, 1 Jun 2009 09:40am EDT(Seeking Alpha) 
9 Trend Leaders
Tuesday, 20 Jan 2009 11:53am EST(SeekingAlpha) 
Selecting 2009 Merger Arbitrages Carefully
Friday, 9 Jan 2009 04:24am EST(SeekingAlpha) 
Hedge Fund Tracking: Seth Klarman & Baupost Group, Q3 2008
Tuesday, 30 Dec 2008 04:57am EST(SeekingAlpha) 
 
Name Current Position Compensation
Guo, Bill Chairman of the Board, Acting Chief Executive Officer --
Harris, Robert President, Director 231,624
Freer, Richard Chief Operating Officer, Director 315,843

Profile

Commonwealth Biotechnologies, Inc. (CBI) is a specialized life sciences outsourcing business that offers a suite of discovery and development services and chemistry and biology products through its subsidiary companies, which include CBI Services, Fairfax Identity Labs (FIL) and Mimotopes Pty... Full Description

Company Address

Commonwealth Biotechnologies, Inc
601 Biotech Drive
Richmond   VA   23235
P: +1804.6483820
F: +1804.6482641

Analyst Research

Performance of Key Competitors

Company Price Change
Qiagen NV $21.64 +0.13
Covance Inc. $53.59 +0.70
Repligen Corporation $4.80 +0.04
  CBTE.DE Industry
P/E(TTM) -- 12.80
P/S(TTM) 0.47 29.90
ROI(TTM) -124.33 2.35
ROE(TTM) -167.13 3.59
No consensus estimates data available.
Total Revenue $2.28M
Net Income $-0.56M
EPS $-0.08